Enrichment RNA analysis showed that CD133 + cells in gastric cancer have high expression of RNA-modifying enzymes that modulate RNA decay, mRNA translation, pre-mRNA processing, and RNA export compared to CD133-negative cells [72]; however, the precise role of CD133 in mRNA processing is unclear. This evidence concerns the gene PROM1 and gastric cancer.